Please assess the completion status of the following clinical trial:

Trial Title: A Study of Fibrocaps™ in Surgical Bleeding

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Has signed an institutional review board/independent ethics committee (IRB/IEC)-approved informed consent document~2. Is undergoing one of the 4 surgical procedures described~3. Is at least 18 years old at time of consent~4. If female and of child-bearing potential, has negative pregnancy test during screening and is not breast-feeding~5. If able to reproduce, agrees to use a medically accepted form of contraception from the time of consent to completion of all follow-up study visits when engaging in heterosexual intercourse~6. Has not received blood transfusion between screening and study treatment~7. Has mild to moderate surgical bleeding~8. Does not have intra-operative complications~9. Has not used a topical hemostat containing thrombin prior to study treatment~10. Has an approximate bleeding site surface area of less than or equal to 100 cm\^2~Exclusion Criteria:~1. Has known antibodies or hypersensitivity to thrombin or other coagulation factors~2. Has history of heparin-induced thrombocytopenia (only for vascular subjects where heparin use is required)~3. Has known allergy to gelatin sponge~4. Is unwilling to receive blood products~5. Has liver enzymes appropriate for the study, considering their disease~6. Has appropriate level of platelets per liter (PLT/L) during screening~7. Has any clinically-significant coagulation disorder that may interfere with the assessment of efficacy or pose a safety risk to the subject according to the Investigator, or baseline abnormalities during screening that are not explained by current drug treatment (e.g., warfarin, heparin)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fibrocaps + Gelatin Sponge (Type: EXPERIMENTAL): Single application of Fibrocaps plus gelatin sponge.
- Gelatin Sponge (Type: ACTIVE_COMPARATOR): Single application of gelatin sponge alone.

Based on this trial design, predict the completion outcome and termination type (if applicable).